0
0
Home > Pharmaceuticals >  COVID-19 >  Coronavirus Disease 2019 (COVID-19) Impact on Pharmaceutical Trade and Supply Chain – Q1 2020 Survey

Coronavirus Disease 2019 (COVID-19) Impact on Pharmaceutical Trade and Supply Chain – Q1 2020 Survey

This report provides an assessment of how the pharmaceutical industry perceives the supply chain disruption caused by the COVID-19 pandemic, including the challenges associated with clinical trials, logistics, API and finished dose manufacturing.

Since the first case was diagnosed in Wuhan, China, in December 2019, COVID-19 cases have continued to rise rapidly across the globe.

Scope

GlobalData’s Coronavirus Disease 2019 (COVID-19) Sector Impact: Pharmaceutical Trade and Supply Chain Survey – Q1 2020 provides in-house analyst expertise on the results of a 5 minute survey of 136 GlobalData Pharma clients and prospects, which was fielded from March 13, 2020 to March 24, 2020.

Reasons to buy

Objectives included:

Benchmark companies’ primary concerns

Determine the impact of COVID-19 to date on supply chains

Assess companies’ strategic future plans

Track changes to corporate strategy and attitudes

Table of Contents

1 Study Design

2 Primary Business Concerns

3 Impact of COVID-19 on Company Revenue

4 Dedicated Planning Team

5 Supply Chain Concerns

6 Clinical Trial Concerns

7 Planning Scenarios

8 Summary

9 Appendix

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports